|
15/11/2016 |
EC122 HER-1 Prostate Phase I |
CIM |
Registered |
|
12/10/2016 |
NGcGM3/VSSP and nimotuzumab in patients with triple negative breast cancer |
CIM |
Registered |
|
30/09/2016 |
D004 vs terazosin |
CPN |
Registered |
|
01/09/2016 |
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma |
CIM |
Registered outdated |
|
30/06/2016 |
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV |
CIM |
Registered |
|
27/05/2016 |
COURAGE Study |
CIGB |
Registered |
|
22/04/2016 |
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
CIM |
Registered |
|
11/03/2016 |
Biograft-G in Dentistry |
BIOMAT |
Registered |
|
11/03/2016 |
Dermofural-diabetic foot ulcers |
CBQ |
Registered |
|
01/02/2016 |
Determination of the local inflammatory response in patients with COPD by wood smoke and COPD per cigarette |
FNC |
Registered |
|
01/02/2016 |
CIGB-370 in patients with malignant tumors |
CIGB |
Registered |
|
29/01/2016 |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
CIM |
Registered |
|
15/12/2015 |
Vaxira as adjuvant treatment for non-small cell lung cancer |
CIM |
Registered outdated |
|
15/12/2015 |
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
CIM |
Registered |
|
14/12/2015 |
CIMAvax-EGF vaccine Predictor Phase IV |
CIM |
Registered outdated |
|
04/12/2015 |
Dose scale-up and cohort expansion with the therapeutic mAb 14F7 |
CIM |
Registered outdated |
|
04/12/2015 |
Study of the meningococcal ACW135 polysaccharide vaccine |
FINLAY |
Registered |
|
19/11/2015 |
EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS |
CLS |
Registered |
|
08/10/2015 |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
CIM |
Registered |
|
25/09/2015 |
Seawater-Rhinitis-Children-Phase III |
UDEA |
Registered |
